|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1990-2-14
|
|
pubmed:abstractText |
An 80-kilodalton glycoprotein (gp80) was produced in human immunodeficiency virus type 2 (HIV-2)-infected cells along with three envelope glycoproteins that we have recently reported: the extracellular glycoprotein (gp125), the envelope glycoprotein precursor (gp140), and the transient dimeric form of the precursor (gp300). gp125 and gp80 were detectable after the synthesis of gp140 and the formation of gp300. Using a specific monoclonal antibody, we showed here that gp80 is a dimeric form of the transmembrane glycoprotein gp36 of HIV-2. Dimerization of the envelope glycoprotein precursor and dimeric forms of the transmembrane glycoproteins were also observed in cells infected with simian immunodeficiency virus (SIV-mac), a virus closely related to HIV-2. Under routine conditions of our experiments (i.e., extraction by 1% Triton X-100 before polyacrylamide gel electrophoresis in sodium dodecyl sulfate [SDS]), monomeric forms of the transmembrane glycoprotein of HIV-2 and SIV-mac were only seldomly observed. Dimeric forms of the envelope precursors and the transmembrane glycoproteins are probably stabilized by extraction in the nonionic detergent Triton X-100 since such dimeric forms resist dissociation during subsequent electrophoresis in the presence of the ionic detergent SDS. However, the dissociation of these dimeric forms might occur when samples are prepared by extraction directly in 1% SDS or by incubation of the purified dimers at acidic pH. Dimerization of the envelope precursor might be required for its processing to give the mature envelope proteins, whereas the transmembrane dimer might be essential for optimal structure of the virion and thus its infectivity.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-1172191,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-2414918,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-2425430,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-2438302,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-2464704,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-2578615,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-2756243,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-2786089,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-2847170,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-2879971,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-2911118,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-2981635,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-3014542,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-3019557,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-3025743,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-3031510,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-3040705,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-3159089,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-3479429,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-3649576,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-3757030,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-3972812,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-6189183,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-6200935,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-7464906,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2296088-867833
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0022-538X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
922-6
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:2296088-Amino Acid Sequence,
pubmed-meshheading:2296088-Blotting, Western,
pubmed-meshheading:2296088-Cell Line,
pubmed-meshheading:2296088-Cell Transformation, Viral,
pubmed-meshheading:2296088-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:2296088-HIV-2,
pubmed-meshheading:2296088-Humans,
pubmed-meshheading:2296088-Macromolecular Substances,
pubmed-meshheading:2296088-Membrane Glycoproteins,
pubmed-meshheading:2296088-Molecular Sequence Data,
pubmed-meshheading:2296088-Molecular Weight,
pubmed-meshheading:2296088-Simian immunodeficiency virus,
pubmed-meshheading:2296088-Viral Envelope Proteins
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers.
|
|
pubmed:affiliation |
Unité d'Oncologie Virale (CNRS URA 1157), Institut Pasteur, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
